Literature DB >> 11017797

Characterization of the humoral immune response and virus replication in cats experimentally infected with feline foamy virus.

A Alke1, A Schwantes, M Zemba, R M Flügel, M Löchelt.   

Abstract

Cats were experimentally infected with cell culture-adapted feline foamy virus (FFV, spumaretrovirinae) isolate FUV. FFV was consistently recovered from peripheral blood leukocytes and throat samples of FFV-infected cats starting 2 to 3 weeks postinfection (p. i.), indicative of the establishment of persistent FFV infections. Viral persistence was established, even despite neutralizing antibodies that appeared early after infection. The humoral immune response toward FFV was quantitatively and qualitatively analyzed over time. FFV Gag-specific antibodies were first detected 2 weeks p. i. and increased further; reactivities to the other structural and nonstructural FFV proteins appeared slightly delayed. Reactivities against FFV Pol and Gag proteins were detectable by immunoblotting and radioimmunoprecipitation, whereas the latter techniques had to be employed for the unambiguous detection of FFV Env-, Bet-, and Bel 1-specific antibodies. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017797     DOI: 10.1006/viro.2000.0537

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet.

Authors:  Mario Perkovic; Stanislaw Schmidt; Daniela Marino; Rebecca A Russell; Benjamin Stauch; Henning Hofmann; Ferdinand Kopietz; Björn-Philipp Kloke; Jörg Zielonka; Heike Ströver; Johannes Hermle; Dirk Lindemann; Vinay K Pathak; Gisbert Schneider; Martin Löchelt; Klaus Cichutek; Carsten Münk
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

2.  Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery.

Authors:  Michael Mühle; Kerstin Hoffmann; Martin Löchelt; Joachim Denner
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

3.  Cell-type-specific regulation of the two foamy virus promoters.

Authors:  C D Meiering; C Rubio; C May; M L Linial
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain.

Authors:  T Wilk; V Geiselhart; M Frech; S D Fuller; R M Flügel; M Löchelt
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Furin-mediated cleavage of the feline foamy virus Env leader protein.

Authors:  Verena Geiselhart; Patrizia Bastone; Tore Kempf; Martina Schnölzer; Martin Löchelt
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 6.  Immunising with the transmembrane envelope proteins of different retroviruses including HIV-1: a comparative study.

Authors:  Joachim Denner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

7.  Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.

Authors:  Astrid Schwantes; Uwe Truyen; Joachim Weikel; Christian Weiss; Martin Löchelt
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction.

Authors:  Dragana Slavkovic Lukic; Agnes Hotz-Wagenblatt; Janet Lei; Ann-Mareen Räthe; Michael Mühle; Joachim Denner; Carsten Münk; Martin Löchelt
Journal:  Retrovirology       Date:  2013-07-24       Impact factor: 4.602

Review 9.  Feline foamy virus-based vectors: advantages of an authentic animal model.

Authors:  Weibin Liu; Janet Lei; Yang Liu; Dragana Slavkovic Lukic; Ann-Mareen Räthe; Qiuying Bao; Timo Kehl; Anne Bleiholder; Torsten Hechler; Martin Löchelt
Journal:  Viruses       Date:  2013-07-12       Impact factor: 5.048

10.  Molecular Epidemiology and Whole-Genome Analysis of Bovine Foamy Virus in Japan.

Authors:  Hirohisa Mekata; Tomohiro Okagawa; Satoru Konnai; Takayuki Miyazawa
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.